Info Tooltip

Premium Info (Not Yet Available)

Free: 3 months of data free.
Premium: Longer timeframes, improved filtering tools, no ads.

Most Recent 50 'COVID' Related ASX Announcements

These results are the type of thing you could search for in the Announcements Filter tool. In this case, we've searched for 'COVID' while 'COVID + Clinical Trial' could be a similarly interesting search.
Market SensitiveDateCompanyAnnouncement
23 May CYC Technegas used in Diagnosing Long COVID
Yes 22 May TYR COVID-19 Trading Update 114 - Week Ended 20 May 2022
Yes 17 May ADO Updated COVID-19 RAT receives Regulatory Approval in Europe
Yes 15 May REG COVID-19 Cost Impacts and Status of Government Grants
Yes 15 May TYR COVID-19 Trading Update 113 - Week Ended 13 May 2022
Yes 08 May TYR COVID-19 Trading Update 112 - Week Ended 6 May 2022
Yes 08 May EHE Ongoing Impact of COVID-19
Yes 01 May TYR COVID-19 Trading Update 111 - Week Ended 29 April 2022
Yes 25 Apr TYR COVID-19 Trading Update 110 - Week Ended 22 April 2022
Yes 18 Apr TYR COVID-19 Trading Update 109 - Week Ended 15 April 2022
Yes 10 Apr TYR COVID-19 Trading Update 108 - Week Ended 8 April 2022
Yes 03 Apr TYR COVID-19 Trading Update 107 - Week Ended 1 April 2022
Yes 27 Mar TYR COVID-19 Trading Update 106 - Week Ended 25 March 2022
Yes 27 Mar SBM Simberi COVID-19 outbreak under control, FY22 guidance
22 Mar RAP COVID-19 Investor Presentation
Yes 17 Mar BIT BIT225 Effectiveness Against COVID-19 in Animals
Yes 13 Mar TYR COVID-19 Trading Update 104 - Week Ended 11 March 2022
Yes 06 Mar TYR COVID-19 Trading Update 103 - Week Ended 4 March 2022
Yes 27 Feb TYR COVID-19 Trading Update 102 - Week Ended 25 February 2022
Yes 27 Feb DXB DSMB Change to REMAP-CAP COVID-19 Study
Yes 24 Feb ANP Long COVID-19 strategic collaboration with US Experts
Yes 23 Feb GTG US Patent Office Grants Patent for COVID-19 Risk Test
Yes 21 Feb SOM Revenues on track despite COVID-19 disruptions
Yes 20 Feb PAA Key Appointment to Progress MPL COVID-19 Clinical Trial
Yes 20 Feb TYR COVID-19 Trading Update 101 - Week Ended 18 February 2022
18 Feb SBM COVID-19 Outbreak at Simberi FY22 guidance withdrawn
Yes 13 Feb TYR COVID-19 Trading Update 100 - Week Ended 11 February 2022
Yes 06 Feb TYR COVID-19 Trading Update 99 - Week Ended 4 February 2022
Yes 30 Jan TYR COVID-19 Trading Update 98 - Week Ended 28 January 2022
Yes 26 Jan AT1 Atomo receives approval for its COVID-19 antigen test in NZ
26 Jan RAP Further appointments to COVID-19 Scientific Advisory Board
Yes 23 Jan TYR COVID-19 Trading Update 97 - Week Ended 21 January 2022
Yes 20 Jan WHC Dec 21 Quarterly & FY22 guidance - La Nina & COVID impacts
Yes 18 Jan AMT COVID 19 and FY2022 Results Guidance
16 Jan RAP Publication highlights use of ResAppDx in COVID-19 clinic
Yes 16 Jan TYR COVID-19 Trading Update 96 - Week Ended 14 January 2022
Yes 12 Jan AHQ New Elk Mine Reports Covid 19 Cases
Yes 10 Jan DXB Patients Dosed in DMX-200 COVID-19 Phase 3 Study in India
Yes 09 Jan RAP US COVID-19 study completes recruitment
Yes 09 Jan TYR COVID-19 Trading Update 95 - Week Ended 7 January 2022
Yes 03 Jan TYR COVID-19 Trading Update 94 - Week Ended 31 December 2021
Yes 28 Dec TYR COVID-19 Trading Update 93 - Week Ended 24 December 2021
Yes 22 Dec DXB Ethics Approval in Australia for Phase 3 COVID-19 Study
Yes 20 Dec MXC ArtemiC Long COVID Syndrome Clinical Study Commenced
Yes 19 Dec TYR COVID-19 Trading Update 92 - Week Ended 17 December 2021
Yes 16 Dec DXB DSMB Recommends Continuation of Ph3 COVID-19 Study in Europe
16 Dec BIT Update on Biotron HIV-1 And COVID-19 Programs
Yes 12 Dec TYR COVID-19 Trading Update 91 - Week Ended 10 December 2021
07 Dec RAP ResApp Establishes COVID-19 Scientific Advisory Board
Yes 05 Dec TYR COVID-19 Trading Update 90 - Week Ended 3 December 2021